RESUMO
We recently reported on a new class of branched amphiphilic peptides that associate with double stranded DNA and promote in vitro transfection of eukaryotic cells. In the present study, we tested a different formulation in which plasmid DNA associates with the surface of preformed 20-30nm cationic capsules formed through the self-assembly of the two branched amphiphilic peptides. Under these conditions, the negatively charged DNA interacts with the cationic surface of the Branched Amphiphilic Peptide Capsules (BAPCs) through numerous electrostatic interactions generating peptide-DNA complexes with sizes ranging from 50 to 250nm. The BAPCs-DNA nanoparticles are capable of delivering plasmid DNA of different size into cells in culture, yielding high transfection rates and minimal cytotoxicity. Furthermore, BAPCs were tested for in vivo delivery of a DNA vaccine previously designed to activate immune responses and capable of controlling tumors induced by type 16 human papilloma virus (HPV-16). The BAPCs-DNA nanoparticles enhanced the vaccine-induced antitumor protection and promoted activation of murine dendritic cells without significant toxic effects. These results indicate that branched amphiphilic oligo-peptides nanoparticles represent a new and promising nonviral DNA/gene delivery approach endowing immunomodulatory properties for DNA vaccines.
Assuntos
DNA/administração & dosagem , Técnicas de Transferência de Genes , Peptídeos/química , Plasmídeos/administração & dosagem , Tensoativos/química , Vacinas de DNA/administração & dosagem , Animais , Linhagem Celular Tumoral , DNA/genética , Células Dendríticas/imunologia , Papillomavirus Humano 16/imunologia , Interações Hidrofóbicas e Hidrofílicas , Camundongos , Nanocápsulas , Neoplasias/imunologia , Neoplasias/prevenção & controle , Plasmídeos/genética , Vacinas de DNA/genética , Vacinas de DNA/imunologiaRESUMO
Colonization surface antigens (CSs) represent key virulence-associated factors of enterotoxigenic Escherichia coli (ETEC) strains. They are required for gut colonization, the first step of the diarrhoeal disease process induced by these bacteria. One of the most prevalent CSs is CS21, or longus, a type IV pili associated with bacterial self-aggregation, protection against environmental stresses, biofilm formation and adherence to epithelial cell lines. The objectives of this study were to assess the role of CS21 in adherence to primary intestinal epithelial cells and to determine if CS21 contributes to the pathogenesis of ETEC infection in vivo. We evaluated adherence of a CS21-expressing wild-type ETEC strain and an isogenic CS21-mutant strain to pig-derived intestinal cell lines. To determine the role of CS21 in pathogenesis we used the above ETEC strains in a neonatal mice challenge infection model to assess mortality. Quantitative adherence assays confirmed that ETEC adheres to primary intestinal epithelial cells lines in a CS21-dependent manner. In addition, the CS21-mediated ETEC adherence to cells was specific as purified LngA protein, the CS21 major subunit, competed for binding with the CS21-expressing ETEC while specific anti-LngA antibodies blocked adhesion to intestinal cells. Neonatal DBA/2 mice died after intra-stomach administration of CS21-expressing strains while lack of CS21 expression drastically reduced the virulence of the wild-type ETEC strain in this animal model. Collectively these results further support the role of CS21 during ETEC infection and add new evidence on its in vivo relevance in pathogenesis.
Assuntos
Adesinas Bacterianas/metabolismo , Aderência Bacteriana , Toxinas Bacterianas/metabolismo , Escherichia coli Enterotoxigênica/fisiologia , Escherichia coli Enterotoxigênica/patogenicidade , Células Epiteliais/microbiologia , Proteínas de Escherichia coli/metabolismo , Fímbrias Bacterianas/fisiologia , Adesinas Bacterianas/genética , Animais , Animais Recém-Nascidos , Toxinas Bacterianas/genética , Células Cultivadas , Infecções por Escherichia coli/microbiologia , Infecções por Escherichia coli/patologia , Proteínas de Escherichia coli/genética , Deleção de Genes , Camundongos , Camundongos Endogâmicos DBA , Análise de Sobrevida , Suínos , Virulência , Fatores de Virulência/genética , Fatores de Virulência/metabolismoRESUMO
Anti-cancer DNA vaccines have attracted growing interest as a simple and non-invasive method for both the treatment and prevention of tumors induced by human papillomaviruses. Nonetheless, the low immunogenicity of parenterally administered vaccines, particularly regarding the activation of cytotoxic CD8+ T cell responses, suggests that further improvements in both vaccine composition and administration routes are still required. In the present study, we report the immune responses and anti-tumor effects of a DNA vaccine (pgD-E7E6E5) expressing three proteins (E7, E6, and E5) of the human papillomavirus type 16 genetically fused to the glycoprotein D of the human herpes simplex virus type 1, which was administered to mice by the intradermal (id) route using a gene gun. A single id dose of pgD-E7E6E5 (2 µg/dose) induced a strong activation of E7-specific interferon-γ (INF-γ)-producing CD8+ T cells and full prophylactic anti-tumor effects in the vaccinated mice. Three vaccine doses inhibited tumor growth in 70 percent of the mice with established tumors. In addition, a single vaccine dose consisting of the co-administration of pgD-E7E6E5 and the vector encoding interleukin-12 or granulocyte-macrophage colony-stimulating factor further enhanced the therapeutic anti-tumor effects and conferred protection to 60 and 50 percent of the vaccinated mice, respectively. In conclusion, id administration of pgD-E7E6E5 significantly enhanced the immunogenicity and anti-tumor effects of the DNA vaccine, representing a promising administration route for future clinical trials.
Assuntos
Animais , Feminino , Camundongos , Vacinas Anticâncer/administração & dosagem , /imunologia , Proteínas Oncogênicas Virais/imunologia , Simplexvirus/imunologia , Vacinas de DNA/administração & dosagem , Proteínas do Envelope Viral/imunologia , /imunologia , Vacinas Anticâncer/genética , Vacinas Anticâncer/imunologia , /genética , Injeções Intradérmicas , Neoplasias Experimentais/imunologia , Neoplasias Experimentais/prevenção & controle , Proteínas Oncogênicas Virais/genética , Simplexvirus/genética , Vacinas de DNA/genética , Vacinas de DNA/imunologia , Proteínas do Envelope Viral/genéticaRESUMO
Anti-cancer DNA vaccines have attracted growing interest as a simple and non-invasive method for both the treatment and prevention of tumors induced by human papillomaviruses. Nonetheless, the low immunogenicity of parenterally administered vaccines, particularly regarding the activation of cytotoxic CD8+ T cell responses, suggests that further improvements in both vaccine composition and administration routes are still required. In the present study, we report the immune responses and anti-tumor effects of a DNA vaccine (pgD-E7E6E5) expressing three proteins (E7, E6, and E5) of the human papillomavirus type 16 genetically fused to the glycoprotein D of the human herpes simplex virus type 1, which was administered to mice by the intradermal (id) route using a gene gun. A single id dose of pgD-E7E6E5 (2 µg/dose) induced a strong activation of E7-specific interferon-γ (INF-γ)-producing CD8+ T cells and full prophylactic anti-tumor effects in the vaccinated mice. Three vaccine doses inhibited tumor growth in 70% of the mice with established tumors. In addition, a single vaccine dose consisting of the co-administration of pgD-E7E6E5 and the vector encoding interleukin-12 or granulocyte-macrophage colony-stimulating factor further enhanced the therapeutic anti-tumor effects and conferred protection to 60 and 50% of the vaccinated mice, respectively. In conclusion, id administration of pgD-E7E6E5 significantly enhanced the immunogenicity and anti-tumor effects of the DNA vaccine, representing a promising administration route for future clinical trials.
Assuntos
Vacinas Anticâncer/administração & dosagem , Papillomavirus Humano 16/imunologia , Proteínas Oncogênicas Virais/imunologia , Simplexvirus/imunologia , Vacinas de DNA/administração & dosagem , Proteínas do Envelope Viral/imunologia , Animais , Linfócitos T CD8-Positivos/imunologia , Vacinas Anticâncer/genética , Vacinas Anticâncer/imunologia , Feminino , Papillomavirus Humano 16/genética , Injeções Intradérmicas , Camundongos , Camundongos Endogâmicos C57BL , Neoplasias Experimentais/imunologia , Neoplasias Experimentais/prevenção & controle , Proteínas Oncogênicas Virais/genética , Simplexvirus/genética , Vacinas de DNA/genética , Vacinas de DNA/imunologia , Proteínas do Envelope Viral/genéticaRESUMO
No effective vaccine or immunotherapy is presently available for patients with the hemolytic uremic syndrome (HUS) induced by Shiga-like toxin (Stx) producedbyenterohaemorragic Escherichia coli (EHEC) strains, such as those belonging to the O157:H7 serotype. In this work we evaluated the performance of Bacillus subtilis strains, a harmless spore former gram-positive bacterium species, as a vaccine vehicle for the expression of Stx2B subunit (Stx2B). A recombinant B. subtilis vaccine strain expressing Stx2B under the control of a stress inducible promoter was delivered to BALB/c mice via oral, nasal or subcutaneous routes using both vegetative cells and spores. Mice immunized with vegetative cells by the oral route developed low but specific anti-Stx2B serum IgG and fecal IgA responses while mice immunized with recombinant spores developed anti-Stx2B responses only after administration via the parenteral route. Nonetheless, serum anti-Stx2B antibodies raised in mice immunized with the recombinant B. subtilis strain did not inhibit the toxic effects of the native toxin, both under in vitro and in vivo conditions, suggesting that either the quantity or the quality of the induced immune response did not support an effective neutralization of Stx2 produced by EHEC strains.
Até o presente o momento, não há vacina ou imunoterapia disponível para pacientes com Síndrome Hemolítica Urêmica (SHU) induzida pela toxina Shiga-like (Stx) produzida por linhagens de Escherichia coli entero-hemorragica (EHEC), tais como as pertencentes ao sorotipo O157:H7. Neste trabalho, avaliamos a performance de Bacillus subtilis, uma espécie bacteriana gram-positiva não-patogênica formadora de esporos, como veículo vacinal para a expressão da subunidade B da Stx2B (Stx2B). Uma linhagem vacinal recombinante de B. subtilis expressando Stx2B, sob o controle de um promoter induzível por estresse, foi administrada a camundongos BALB/c por via oral, nasal ou subcutânea usando células vegetativas e esporos. Camundongos imunizados com células vegetativas e esporos pela via oral desenvolveram títulos anti-Stx2B baixos, mas específicos, de IgG sérico e IgA fecal, enquanto camundongos imunizados com esporos recombinates desenvolveram resposta anti-Stx2B apenas após a administração pela via parenteral. No entanto, anticorpos produzidos em camundongos imunizados com a linhagem recombinante de B. subtilis não inibiram os efeitos tóxicos da toxina nativa em condições in vitro e in vivo, sugerindo que a quantidade e/ou a qualidade da resposta imune gerada não suportam uma neutralização efetiva da Stx2 produzidas por linhagens de EHEC.
Assuntos
Animais , Camundongos , Escherichia coli Êntero-Hemorrágica , Anticorpos Antibacterianos/análise , Bacillus subtilis/isolamento & purificação , Técnicas In Vitro , Vacinas Bacterianas , Camundongos , Esporos Bacterianos , Métodos , Sorotipagem , MétodosRESUMO
In the present study we investigated the flagellin-specific serum (IgG) and fecal (IgA) antibody responses elicited in BALB/c mice immunized with isogenic mutant derivatives of the attenuated Salmonella enterica serovar Typhimurium (S. Typhimurium) SL3261 strain expressing phase 1 (FliCi), phase 2 (FljB), or no endogenous flagellin. The data reported here indicate that mice orally immunized with recombinant S. Typhimurium strains do not mount significant systemic or secreted antibody responses to FliCi, FljB or heterologous B-cell epitopes genetically fused to FliCi. These findings are particularly relevant for those interested in the use of flagellins as molecular carriers of heterologous antigens vectored by attenuated S. Typhimurium strains.
Assuntos
Animais , Camundongos , Anticorpos Antibacterianos/sangue , Flagelina/imunologia , Vacinas contra Salmonella/imunologia , Salmonella typhimurium/imunologia , Administração Oral , Vacinas Bacterianas/imunologia , Camundongos Endogâmicos BALB C , Vacinas contra Salmonella/administração & dosagem , Vacinas Atenuadas/imunologiaRESUMO
The oligopeptide-binding protein, OppA, binds and ushers oligopeptide substrates to the membrane-associated oligopeptide permease (Opp), a multi-component ABC-type transporter involved in the uptake of oligopeptides expressed by several bacterial species. In the present study, we report the cloning, purification, refolding and conformational analysis of a recombinant OppA protein derived from Xanthomonas axonopodis pv. citri (X. citri), the etiological agent of citrus canker. The oppA gene was expressed in Escherichia coli BL21 (DE3) strain under optimized inducing conditions and the recombinant protein remained largely insoluble. Solubilization was achieved following refolding of the denatured protein. Circular dichroism analysis indicated that the recombinant OppA protein preserved conformational features of orthologs expressed by other bacterial species. The refolded recombinant OppA represents a useful tool for structural and functional analyses of the X. citri protein.
Assuntos
Dobramento de Proteína , Proteínas de Bactérias/isolamento & purificação , Proteínas de Membrana Transportadoras/isolamento & purificação , Proteínas de Transporte/metabolismo , Xanthomonas axonopodis/genética , Sequência de Aminoácidos , Sequência de Bases , Biologia Computacional/métodos , Dicroísmo Circular , Clonagem Molecular , Escherichia coli/genética , Dados de Sequência Molecular , Óperon , Plasmídeos , Conformação Proteica , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Proteínas de Bactérias/química , Proteínas de Transporte/genética , Proteínas de Transporte/isolamento & purificação , Xanthomonas axonopodis/metabolismoRESUMO
The oligopeptide-binding protein, OppA, ushers oligopeptide substrates to the membrane-associated oligopeptide permease (Opp), a multi-component ABC-type transporter involved in the uptake of oligopeptides by several bacterial species. In the present study, we report a structural model and an oligopeptide docking analysis of the OppA protein expressed by Xanthomonas axonopodis pv. citri (X. citri), the etiological agent of citrus canker. The X. citri OppA structural model showed a conserved three-dimensional structure, irrespective of the low amino acid identities with previously defined structures of Bacillus subtilis and Salmonella typhimurium orthologs. Oligopeptide docking analysis carried out with the proposed model indicated that the X. citri OppA preferentially binds tri- and tetrapeptides. The present study represents the first structural analysis of an OppA ortholog expressed by a phytopathogen and contributes to the understanding of the physiology and nutritional strategies of X. citri.
Assuntos
Lipoproteínas/química , Oligopeptídeos/metabolismo , Proteínas de Bactérias/química , Proteínas de Transporte/química , Xanthomonas/metabolismo , Sequência de Aminoácidos , Sítios de Ligação , Doenças das Plantas/microbiologia , Ligantes , Modelos Moleculares , Dados de Sequência Molecular , Conformação ProteicaAssuntos
Animais , Masculino , Feminino , Quirópteros/fisiologia , Reprodução/fisiologia , Maturidade Sexual/fisiologiaRESUMO
Environmental and genetic factors affecting the in vitro spontaneous mutation frequencies to aminoglycoside resistance in Escherichia coli K12 were investigated. Spontaneous mutation frequencies to kanamycin resistance were at least 100 fold higher on modified Luria agar (L2) plates, when compared to results obtained in experiments carried out with Nutrient agar (NA) plates. In contrast to rifampincin, the increased mutability to kanamycin resistance could not be attributed to a mutator phenotype expressed by DNA repair defective strains. Kanamycin mutant selection windows and mutant preventive concentrations on L2 plates were at least fourfold higher than on NA plates, further demonstrating the role of growth medium composition on the mutability to aminoglycosides. Mutability to kanamycin resistance was increased following addition of sorbitol, suggesting that osmolarity is involved on the spontaneous mutability of E. coli K12 strains to aminoglycosides. The spontaneous mutation rates to kanamycin resistance on both L2 and NA plates were strictly associated with the selective antibiotic concentrations. Moreover, mutants selected at different antibiotic concentrations expressed heterogeneous resistance levels to kanamycin and most of them expressing multiple resistance to all tested aminoglycoside antibiotics (gentamicin, neomycin, amykacin and tobramycin). These results will contribute to a better understanding of the complex nature of aminoglycoside resistance and the emergence of spontaneous resistant mutants among E. coli K12 strains
Assuntos
Aminoglicosídeos , Escherichia coli , Mutação/genética , Resistência Microbiana a Medicamentos , Meio AmbienteRESUMO
Stimulation of the mammalian immune system by administration of plasmid DNA has been shown to be an important approach for vaccine development against several pathogens. In the present study we investigated the use of DNA vaccines to induce immune responses against an enteric bacterial pathogen, enterotoxigenic Escherichia coli (ETEC). Three plasmid vectors encoding colonization factor antigen I (CFA/I), an ETEC fimbrial adhesin, were constructed. Eukaryotic cells transfected with each of these plasmids expressed the heterologous antigen in different compartments: bound to the cytoplasmic membrane (pRECFA), accumulated in the cytoplasm (pPolyCFA) or secreted to the outside medium (pBLCFA). BALB/c mice were intramuscularly (im) inoculated with purified plasmid DNA and the systemic, cellular and secreted CFA/I-specific immune responses were analyzed. The results showed that all three DNA vaccine formulations could elicit CFA/I-specific immune responses. Moreover, cellular location of the plasmid-encoded CFA/I seems to have an important role in the induced immune response. Taken together, these results indicate that DNA vaccines also represent a promising approach against enteric bacterial pathogens
Assuntos
Animais , Camundongos , Adesinas de Escherichia coli , Proteínas de Bactérias/imunologia , Vacinas Bacterianas , Enterotoxinas , Escherichia coli/imunologia , Vacinas de DNA , Camundongos Endogâmicos BALB CRESUMO
The induction of systemic (IgG) and mucosal (IgA) antibody responses against the colonization factor I antigen (CFA/I) of enterotoxigenic Escherichia coli (ETEC) was evaluated in mice primed with an intramuscularly delivered CFA/I-encoding DNA vaccine followed by two oral immunizations with a live recombinant Salmonella typhimurium vaccine strain expressing the ETEC antigen. The booster effect induced by the oral immunization was detected two weeks and one year after the administration of the DNA vaccine. The DNA-primed/Salmonella-boosted vaccination regime showed a synergistic effect on the induced CFA/I-specific systemic and secreted antibody levels which could not be attained by either immunization strategy alone. These results suggest that the combined use of DNA vaccines and recombinant Salmonella vaccine strains can be a useful immunization strategy against enteric pathogens
Assuntos
Animais , Camundongos , Adesinas de Escherichia coli , Proteínas de Bactérias/imunologia , Vacinas Bacterianas , Enterotoxinas , Escherichia coli/imunologia , Imunização Secundária , Salmonella typhimurium/imunologia , Vacinas de DNA , Formação de Anticorpos , Imunidade nas Mucosas , Camundongos Endogâmicos BALB C , Infecções por Salmonella/imunologiaRESUMO
An expression plasmid (pCFA-1) carrying the cfaB gene that codes for the enterotoxigenic Escherichia coli (ETEC) fimbrial adhesin colonization factor antigen I(CFA/I) subunit was constructed and used to transform a derivative of the attenuated Salmonella typhimurium aroA vaccine strain SL3261 carrying an F'lacl(q). Treatment of the transformed strain with isopropyl-beta-D-thiogalactopyranoside (IPTG) resulted in elevated in vitro expression of the CFA/I subunit. Although flagellar function and lipopolysaccharide (LPS) synthesis were similar in both the parental and the recombinant strains, spleen colonization was reduced in the recombinant strain. AII BALB/c mice parenteally inoculated with the recombinant strain developed significant anti-CFA/I and anti-LPS serum antibody titers (P<0.05). Moreover, 2 of 5 mice orally inoculated with the engineered Salmonella strain developed anti-CFA/I intestinal IgA (P>0.05) while 4/5 of the same mice developed anti-LPS (P<0.05). The results indicate that the vaccine strain elicited an antibody response against the bacterial host both after oral and intravenous immunization while the response against the CFA/I antigen was significant only after inoculation by the intravenous route.
Assuntos
Animais , Camundongos , Antígenos de Bactérias/imunologia , Vacinas Bacterianas/imunologia , Diarreia , Infecções por Escherichia coli , Salmonella typhimurium/imunologia , Formação de Anticorpos/imunologia , Proteínas de Bactérias , Diarreia/imunologia , Diarreia/microbiologia , Enterotoxinas/biossíntese , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular , Plasmídeos/imunologia , Vacinas Atenuadas , Vacinas SintéticasRESUMO
The outer membrane protein (OMP) and lipopolysaccharide (LPS) patterns of 12 strains of serogroups of enterotoxigenic E. coli frequntly isolated in Säo Paulo city werte determined by fractionation techniques and by sodium dodecyl sulfate-plyacrylamide gel electrophoresis (SDS-PAGE). Five O6, three O78 and four O128 serogroup isolates of different serotypes (flagellar antigens) and virulence factors (toxins and colonization factor antigens) showed a high degree of variability in their OMP pattern and at least nine groups could be identified. The analysis of LPS aptterns by SDS-PAGE showed a homogenous profile for the O6 strains and some minor differences for the O128 and 078 strains. The oresented data indicate that analysis of OMP and LPS by SDS-PAGE may further improve the discriminating ability of extensively used serological techniques or the detection of virulence factors and could be a useful tool in epidemiological studies of enterotoxigenic E. coli (ETEC) strains from this area
Assuntos
Escherichia coli/química , Lipopolissacarídeos/química , Proteínas da Membrana Bacteriana Externa/química , Antígenos de Bactérias/isolamento & purificação , Fracionamento Químico , Eletroforese em Gel de Poliacrilamida , Escherichia coli/imunologia , Escherichia coli/isolamento & purificação , Lipopolissacarídeos/isolamento & purificação , Fenótipo , Proteínas da Membrana Bacteriana Externa/isolamento & purificaçãoRESUMO
The distribution of Yersina pestis Fraction-1 (F1) antigen was analyzed in cells grown at 28§C and 37§C. Fractionation of Y. pestis cells followed by analysis in SDS-polyacrylamide gel electrophoresis indicated that the mature form of the F1 antigen is localized in the extracellular matrix and in the cytoplasm. Localization of the F1 antigen was confirmed by immunoblots and a single peptide with a molecular weight of 17,000 daltons was recognized. Electron microscopy of Y. pestis cells labeled with colloidal gold-conjugated antibodies corroborated the extracellular matrix and cytoplasm dual location of the F1 antigen
Assuntos
Antígenos de Bactérias/isolamento & purificação , Fracionamento Celular , Yersinia pestis/imunologia , Eletroforese em Gel de Poliacrilamida , Peso Molecular , Virulência , Yersinia pestis/patogenicidade , Yersinia pestis/ultraestruturaRESUMO
As atividades mutagenicas de 16 drogas com acao anti-parasitaria foram avaliadas pelo Simultest em ensaios qualitativos (spot testes) e quantitativos (incorporacao em placa) com uma mistura das linhagens indicadoras de Salmonella typhimurium TA97, TA98, TA100 e TA102. Quatro drogas anti-doenca de Chagas (nifurtimox, benzonidazol, CL 64,855 e MK 436) e duas drogas anti-amebiase (metronidazol e tinidazol) deram resultados positivos em testes qualitativos e a incorporacao de fracao microssomal de figado de rato nao alterou os resultados. Curvas comparadas de efeito da dose da atividade mutagenica do metronidazol, benzonidazol e CL 64,855 detectadas oelo Simultest e linhagens indicadoras individuais demonstraram que as duas abordagens possuem sensibilidades semelhantes. Os resultados corroboram a validade do Simultest como uma versao simplificada, rapida e economica do teste de Ames no rastreamento preliminar de drogas potencialmente mutagenicas
Assuntos
Ratos , Animais , Antiprotozoários/farmacocinética , Eucariotos/efeitos dos fármacos , Mutagênicos/efeitos dos fármacos , Salmonella typhimurium/efeitos dos fármacosRESUMO
No presente estudo tres tecnicas para isolamento de fracoes enriquecidas em membrana externa de Y. pestis foram avaliadas. As tecnicas utilizadas foram: centrifugacao em gradiente de densidade em sacarose e solubilizacao diferencial com Sarkosyl ou Triton X-100. A analise por eletroforese em gel de poliacrilamida na presenca de dodecil sulfato de sodio (SDS-PAGE) das membranas externas extraidas pelos diferentes metodos evidenciou perfis proteicos semelhantes. A determinacao das atividades de NADH-desidrogenase e succinato-desidrogenase (enzimas de membrana interna) indicou que todas as preparacoes estudadas eram adequadas a estudos analiticos. Obteve-se evidencias preliminares sobre o possivel uso de perfis proteicos de membrana externa na identificacao de variantes geograficos entre isolados selvagens de Y. pestis
Assuntos
Proteínas da Membrana Bacteriana Externa/isolamento & purificação , Yersinia pestis/metabolismo , Membrana Celular/enzimologia , Centrifugação com Gradiente de Concentração , Eletroforese em Gel de Poliacrilamida , NADH Desidrogenase/metabolismo , Succinato Desidrogenase/metabolismoRESUMO
1. The mutagenicity of serum and urine from fuinea pigs treated with a single oral dose (500 mg/Kg) of benznidazole and nifurtimox was assayed using the Salmonella/plate incorporation test with strain TA100 and a nitroreductase-deficient derivative, TA100NR. 2. The urine and blood of animals treated with nifurtimox were not mutagenic for either tester strain. 3. The urine and blood of animals receiving benznidazole were mutagenic to the TA100 but not to the TA100NR strain. Similar results were obtained with nitrofurantoin-treated animals. Maximum mutagenicity values were obtained in serum and urine of treated animals 90 min and 24 h after administration, respectively. 4. Mutagenicity induced by benznidazole in the serum and urine of treated animals was not altered when assayed in anaerobic environments. 5. These results indicate that benznidazole and nifurtimox are not metabolized by the mammalian host into stable mutagenic derivatives detectable by the Ames test. Based on these data, we suggest that the potential cancer risk to patients treated with these drugs is small but should be further evaluated
Assuntos
Cobaias , Animais , Masculino , Feminino , Testes de Mutagenicidade , Mutação , Nifurtimox/metabolismo , Nitroimidazóis/metabolismoRESUMO
Proteínas de superfície de Escherichia coli K12 foram identificadas por marcaçäo radioativa usando 1,3,4,6-tetracloro, 3-alpha,6-alpha-difenilglicoluril (Iodo-Gen) e I. Proteínas detectadas por este procedimiento de marcaçäo foram localizadas na membrane externa das células. Usando esta técnica foi possível observar diferenças na composiçäo de proteínas de superfície de células em diferentes fases de crescimento. A marcaçäo de células incubadas a 42§ C revelou que as sínteses de duas proteínas de superfície foram induzidas pela temperatura. Resultados adicionais indicaram que pelo menos uma proteína de superfície pode estar envolvida no processo de divisäo celular em E. coli K12
Assuntos
Escherichia coli/genética , Proteínas de Membrana/análise , Eletroforese em Gel de PoliacrilamidaRESUMO
O derivado nitroimizadole-tiadizol CL 64.855 (2-amino-5-(1-metil-5-nitro-2-imidazoli)-1, 3, 4-tiadiazol), um potente agente tripanomicida, foi submetido a um ensaio mutagênico bacteriano com as linhagens indicadoras de Salmonella typhimurium TA 98, TA 100 e TA 102. Os resultados indicaram que o CL 64.855 é um potente mutagênico tipo troca de referencial detectado pelas linhagens TA 98 e TA 102. O CL 64.855 foi capaz de reverter as linhagens indicadoras em concentraçöes täo baixas quatro 0,1microng/placa. Ativaçäo metabólica com fraçöes microssomais de fígado de rato foram incapazes de aumentar a açäo mutagênica do CL 64.855